Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction dose of remimazolam combined with sufentanil for general anesthesia in severely obese patients
ChiCTR2500095487Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in obesity, sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Modified Observer's Assessment of Alertness/Sedation scale (MOAS/S) and Remimazolam ED50. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2500095487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095487.